Price to Book Value (P/BV)
since 2005
Paying user area
Try for free
Abbott Laboratories pages available for free this week:
- Income Statement
- Statement of Comprehensive Income
- Common-Size Income Statement
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Short-term (Operating) Activity Ratios
- Analysis of Reportable Segments
- Enterprise Value to FCFF (EV/FCFF)
- Selected Financial Data since 2005
- Net Profit Margin since 2005
- Debt to Equity since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Abbott Laboratories for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
Abbott Laboratories, P/BV, long-term trends, calculation
| P/BV | = | Share price1, 2, 3 | ÷ | Book value per share1 (BVPS) | BVPS1 | = | Total Abbott shareholders’ investment1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 21, 2025 | = | ÷ | = | ÷ | |||||||
| Feb 16, 2024 | = | ÷ | = | ÷ | |||||||
| Feb 17, 2023 | = | ÷ | = | ÷ | |||||||
| Feb 18, 2022 | = | ÷ | = | ÷ | |||||||
| Feb 19, 2021 | = | ÷ | = | ÷ | |||||||
| Feb 21, 2020 | = | ÷ | = | ÷ | |||||||
| Feb 22, 2019 | = | ÷ | = | ÷ | |||||||
| Feb 16, 2018 | = | ÷ | = | ÷ | |||||||
| Feb 17, 2017 | = | ÷ | = | ÷ | |||||||
| Feb 19, 2016 | = | ÷ | = | ÷ | |||||||
| Feb 27, 2015 | = | ÷ | = | ÷ | |||||||
| Feb 21, 2014 | = | ÷ | = | ÷ | |||||||
| Feb 15, 2013 | = | ÷ | = | ÷ | |||||||
| Feb 21, 2012 | = | ÷ | = | ÷ | |||||||
| Feb 18, 2011 | = | ÷ | = | ÷ | |||||||
| Feb 19, 2010 | = | ÷ | = | ÷ | |||||||
| Feb 20, 2009 | = | ÷ | = | ÷ | |||||||
| Feb 19, 2008 | = | ÷ | = | ÷ | |||||||
| Feb 23, 2007 | = | ÷ | = | ÷ | |||||||
| Feb 22, 2006 | = | ÷ | = | ÷ |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Abbott Laboratories Annual Report.
The share price exhibits fluctuations over the observed period, beginning at $43.90 in early 2006 and reaching a peak of $134.92 by early 2025. Notable declines occur around 2013 at $35.08 and during 2016 at $38.53, indicating episodic market pressures or company-specific factors influencing valuation. Following these troughs, a recovery trend emerges, culminating in a significant rise from 2019 onwards, reflecting enhanced market confidence or improved company performance.
Book value per share (BVPS) shows a general upward trajectory from $9.37 in 2006 to $27.48 in 2025, indicating a steady increase in the company’s net asset value on a per-share basis. While some minor reductions are observable, such as between 2011 ($14.47) and 2017 ($11.89), the overall growth trend suggests sustained asset accumulation or earnings retention contributing to shareholder equity expansion.
The price-to-book value (P/BV) ratio, a measure of market valuation relative to the book value, varies considerably across the years. Starting high at 4.69 in 2006, the ratio peaked at 6.65 in early 2021, signaling elevated investor expectations or market optimism. Conversely, the ratio experienced lows near 2.06 in 2013, which may correspond to undervaluation phases or market skepticism. The P/BV trend largely mirrors the share price volatility but remains above 2.0 consistently, indicating that the market tends to price the company above its book value, reflecting growth prospects or intangible assets not captured in book value.
In summary, the data indicates that while the company’s intrinsic value as represented by book value per share has steadily increased, its market valuation as reflected in share price and P/BV ratio exhibits more pronounced fluctuations. Periods of decline in share price temporarily reduced valuation multiples, yet subsequent recoveries led to elevated market assessments relative to book value. This dynamic suggests an interplay of external market factors and internal performance influencing investor sentiment over time.
Comparison to Competitors
Abbott Laboratories, P/BV, long-term trends, comparison to competitors
| Abbott Laboratories | CVS Health Corp. | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | ||||||
| Feb 16, 2024 | ||||||
| Feb 17, 2023 | ||||||
| Feb 18, 2022 | ||||||
| Feb 19, 2021 | ||||||
| Feb 21, 2020 | ||||||
| Feb 22, 2019 | ||||||
| Feb 16, 2018 | ||||||
| Feb 17, 2017 | ||||||
| Feb 19, 2016 | ||||||
| Feb 27, 2015 | ||||||
| Feb 21, 2014 | ||||||
| Feb 15, 2013 | ||||||
| Feb 21, 2012 | ||||||
| Feb 18, 2011 | ||||||
| Feb 19, 2010 | ||||||
| Feb 20, 2009 | ||||||
| Feb 19, 2008 | ||||||
| Feb 23, 2007 | ||||||
| Feb 22, 2006 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
Abbott Laboratories, P/BV, long-term trends, comparison to sector (health care equipment & services)
| Abbott Laboratories | Health Care Equipment & Services | |
|---|---|---|
| Feb 21, 2025 | ||
| Feb 16, 2024 | ||
| Feb 17, 2023 | ||
| Feb 18, 2022 | ||
| Feb 19, 2021 | ||
| Feb 21, 2020 | ||
| Feb 22, 2019 | ||
| Feb 16, 2018 | ||
| Feb 17, 2017 | ||
| Feb 19, 2016 | ||
| Feb 27, 2015 | ||
| Feb 21, 2014 | ||
| Feb 15, 2013 | ||
| Feb 21, 2012 | ||
| Feb 18, 2011 | ||
| Feb 19, 2010 | ||
| Feb 20, 2009 | ||
| Feb 19, 2008 | ||
| Feb 23, 2007 | ||
| Feb 22, 2006 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Abbott Laboratories, P/BV, long-term trends, comparison to industry (health care)
| Abbott Laboratories | Health Care | |
|---|---|---|
| Feb 21, 2025 | ||
| Feb 16, 2024 | ||
| Feb 17, 2023 | ||
| Feb 18, 2022 | ||
| Feb 19, 2021 | ||
| Feb 21, 2020 | ||
| Feb 22, 2019 | ||
| Feb 16, 2018 | ||
| Feb 17, 2017 | ||
| Feb 19, 2016 | ||
| Feb 27, 2015 | ||
| Feb 21, 2014 | ||
| Feb 15, 2013 | ||
| Feb 21, 2012 | ||
| Feb 18, 2011 | ||
| Feb 19, 2010 | ||
| Feb 20, 2009 | ||
| Feb 19, 2008 | ||
| Feb 23, 2007 | ||
| Feb 22, 2006 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).